Artiva Biotherapeutics (ARTV) Receivables (2023 - 2026)
Artiva Biotherapeutics (ARTV) posted quarterly Receivables of -$67000.0 for Q1 2026, down 128.63% year-over-year from $234000.0 in Q1 2025, and down 458.33% quarter-over-quarter from -$12000.0 in Q4 2025.
Artiva Biotherapeutics (ARTV) Receivables (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported Receivables for 4 consecutive years, with -$67000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables fell 128.63% year-over-year to -$67000.0; the TTM figure through Mar 2026 stood at -$67000.0 (down 128.63% YoY), while the FY2025 annual figure was -$79000.0, up 86.33% from the prior year.
- Receivables declined to -$67000.0 in Q1 2026 per ARTV's latest filing, from -$12000.0 in the prior quarter.
- Across five years, Receivables topped out at $1.8 million in Q4 2023 and bottomed at -$67000.0 in Q1 2026.
- Historically, Receivables has averaged $466444.4 across 4 years, with a median of $79000.0 in 2025.
- On a YoY basis, Receivables climbed as much as 88.73% in 2025 and fell as far as 185.71% in 2025.
- Artiva Biotherapeutics' Receivables stood at $1.8 million in 2023, then plunged by 99.2% to $14000.0 in 2024, then plunged by 185.71% to -$12000.0 in 2025, then plunged by 458.33% to -$67000.0 in 2026.
- Business Quant data shows ARTV's Receivables at -$67000.0 in Q1 2026, -$12000.0 in Q4 2025, and $79000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.93 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.06 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.84 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 912.74 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 215.33 Mn |
| 10 | Artiva Biotherapeutics | 451.28 Mn | 451.28 Mn | - | 141,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 141,000.00 |
| Mar 31, 2026 | -67,000.00 |
| Dec 31, 2025 | -12,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Mar 31, 2025 | 234,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Sep 30, 2024 | 701,000.00 |
| Jun 30, 2024 | 1.46 Mn |
| Dec 31, 2023 | 1.76 Mn |